These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 26006198

  • 1. Rectal indomethacin for the prevention of post-ERCP pancreatitis: A meta-analysis of randomized controlled trials.
    Shi N, Deng L, Altaf K, Huang W, Xue P, Xia Q.
    Turk J Gastroenterol; 2015 May; 26(3):236-40. PubMed ID: 26006198
    [Abstract] [Full Text] [Related]

  • 2. Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A systematic review and meta-analysis.
    Garg R, Mohan BP, Krishnamoorthi R, Rustagi T.
    Indian J Gastroenterol; 2018 Mar; 37(2):120-126. PubMed ID: 29619673
    [Abstract] [Full Text] [Related]

  • 3. A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Sethi S, Sethi N, Wadhwa V, Garud S, Brown A.
    Pancreas; 2014 Mar; 43(2):190-7. PubMed ID: 24518496
    [Abstract] [Full Text] [Related]

  • 4. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
    Lyu Y, Cheng Y, Wang B, Xu Y, Du W.
    BMC Gastroenterol; 2018 Jul 04; 18(1):106. PubMed ID: 29973142
    [Abstract] [Full Text] [Related]

  • 5. How to select patients and timing for rectal indomethacin to prevent post-ERCP pancreatitis: a systematic review and meta-analysis.
    Wan J, Ren Y, Zhu Z, Xia L, Lu N.
    BMC Gastroenterol; 2017 Mar 15; 17(1):43. PubMed ID: 28298192
    [Abstract] [Full Text] [Related]

  • 6. Prophylactic rectal indomethacin may be ineffective for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in general patients: A meta-analysis.
    Feng Y, Navaneethan U, Zhu X, Varadarajulu S, Schwartz I, Hawes R, Hasan M, Yang A.
    Dig Endosc; 2017 May 15; 29(3):272-280. PubMed ID: 27914176
    [Abstract] [Full Text] [Related]

  • 7. Rectal NSAIDs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in unselected patients: Systematic review and meta-analysis.
    Shen C, Shi Y, Liang T, Su P.
    Dig Endosc; 2017 May 15; 29(3):281-290. PubMed ID: 28112441
    [Abstract] [Full Text] [Related]

  • 8. The effect of indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis.
    Ahmad D, Lopez KT, Esmadi MA, Oroszi G, Matteson-Kome ML, Choudhary A, Bechtold ML.
    Pancreas; 2014 Apr 15; 43(3):338-42. PubMed ID: 24622061
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rectal indomethacin is protective against post-ERCP pancreatitis in high-risk patients but not average-risk patients: a systematic review and meta-analysis.
    Inamdar S, Han D, Passi M, Sejpal DV, Trindade AJ.
    Gastrointest Endosc; 2017 Jan 15; 85(1):67-75. PubMed ID: 27612923
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effectiveness of nonsteroidal anti-inflammatory drugs in prevention of post-ERCP pancreatitis: a meta-analysis.
    Li X, Tao LP, Wang CH.
    World J Gastroenterol; 2014 Sep 14; 20(34):12322-9. PubMed ID: 25232268
    [Abstract] [Full Text] [Related]

  • 16. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a cost-effectiveness analysis.
    Nicolás-Pérez D, Castilla-Rodríguez I, Gimeno-García AZ, Romero-García R, Núñez-Díaz V, Quintero E.
    Pancreas; 2015 Mar 14; 44(2):204-10. PubMed ID: 25406954
    [Abstract] [Full Text] [Related]

  • 17. Rectal NSAIDs for the prevention of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
    Sun HL, Han B, Zhai HP, Cheng XH, Ma K.
    Surgeon; 2014 Jun 14; 12(3):141-7. PubMed ID: 24332479
    [Abstract] [Full Text] [Related]

  • 18. A Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in Patients with Suspected Type 3 Sphincter of Oddi Dysfunction.
    Siddiqui AA, Patel D, Kaplan J, Zabolotsky AH, Loren D, Kowalski T, Ghumman SS, Adler DG, Munigal S, Hayat U, Eloubeidi MA.
    Dig Dis Sci; 2015 Aug 14; 60(8):2509-15. PubMed ID: 25868629
    [Abstract] [Full Text] [Related]

  • 19. Nafamostat mesilate for prevention of post-ERCP pancreatitis: a meta-analysis of prospective, randomized, controlled trials.
    Yu G, Li S, Wan R, Wang X, Hu G.
    Pancreas; 2015 May 14; 44(4):561-9. PubMed ID: 25822153
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.